Browse All

Current Filters

CLEAR FILTER x

TITLE

Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorder (TAND) Outcomes Following Add-on Cannabidiol (CBD) Treatment: 3-Month Analysis of Open-Label Phase 3b/4 Trial EpiCom

Author:van Eeghen, Agnies   Wilson, Sarah   Smith, Douglas   Strowd, Roy   Boggs, Jane   Greco, Teresa   Stevens, Joanne   Moore-Ramdin, Lisa   

Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P8.005  

Author Institution:Emma Children’s Hospital, Amsterdam University Medical Centers, Amsterdam, Netherlands  McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX  Minnesota Epilepsy Group, Roseville, MN  Wake Forest School Of Medicine, Winston Salem, NC  Wake Forest School of Medicine, Winston-Salem, NC  Jazz Pharmaceuticals, Inc. , Villa Guardia, Italy  Jazz Pharmaceuticals, Inc., Philadelphia, PA  Jazz Pharmaceuticals, Inc. , London, United Kingdom